{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:33:52Z","timestamp":1790966032881,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12 HS023011"],"award-info":[{"award-number":["K12 HS023011"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04138-6","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T23:26:23Z","timestamp":1743463583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence, severity and predictors of hand eczema in patients treated for atopic dermatitis: a cross-sectional observational study"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3686-7805","authenticated-orcid":false,"given":"Jonathan I.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Samynathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Thyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"3","key":"4138_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2015.01.001","volume":"72","author":"NG Heede","year":"2015","unstructured":"Heede NG, Thyssen JP, Thuesen BH, Linneberg A, Johansen JD (2015) Anatomical patterns of dermatitis in adult filaggrin mutation carriers. J Am Acad Dermatol 72(3):440\u2013448","journal-title":"J Am Acad Dermatol"},{"issue":"10470","key":"4138_CR2","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(24)01810-5","volume":"404","author":"S Weidinger","year":"2024","unstructured":"Weidinger S, Novak N (2024) Hand eczema. Lancet (Br Ed) 404(10470):2476\u20132486. https:\/\/doi.org\/10.1016\/S0140-6736(24)01810-5","journal-title":"Lancet (Br Ed)"},{"issue":"3","key":"4138_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0536.2012.02130.x","volume":"67","author":"J Kaae","year":"2012","unstructured":"Kaae J, Menne T, Carlsen BC, Zachariae C, Thyssen JP (2012) The hands in health and disease of individuals with filaggrin loss-of-function mutations: clinical reflections on the hand eczema phenotype. Contact Dermatitis 67(3):119\u2013124","journal-title":"Contact Dermatitis"},{"issue":"3","key":"4138_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2310\/6620.2006.06005","volume":"17","author":"EL Simpson","year":"2006","unstructured":"Simpson EL, Thompson MM, Hanifin JM (2006) Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis 17(3):123\u2013127","journal-title":"Dermatitis"},{"issue":"9","key":"4138_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/ddg.15179","volume":"21","author":"A Bauer","year":"2023","unstructured":"Bauer A, Brans R, Brehler R, B\u00fcttner M, Dickel H, Elsner P, Fartasch M, Herzog C, John S, K\u00f6llner A, Maul J, Merk H, Molin S, Nast A, Nikolakis GD, Schliemann S, Skudlik C, Weisshaar E, Werfel T, Zidane M, Worm M (2023) S2k guideline diagnosis, prevention, and therapy of hand eczema. J Dtsch Dermatol Ges 21(9):1054\u20131074. https:\/\/doi.org\/10.1111\/ddg.15179","journal-title":"J Dtsch Dermatol Ges"},{"key":"4138_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2340\/00015555924447","volume":"92","author":"J Hanifin","year":"1980","unstructured":"Hanifin J (1980) Diagnostic features of atopic eczema. Acta Dermatol Venereol (Stockh) 92:44\u201347","journal-title":"Acta Dermatol Venereol (Stockh)"},{"key":"4138_CR7","doi-asserted-by":"crossref","unstructured":"Severity scoring of atopic dermatitis: the SCORAD index (1993) Consensus report of the European task force on atopic dermatitis. Dermatology 186(1):23\u201331","DOI":"10.1159\/000247298"},{"issue":"5","key":"4138_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/bjd.15641","volume":"177","author":"R Chopra","year":"2017","unstructured":"Chopra R, Vakharia PP, Sacotte R et al (2017) Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol 177(5):1316\u20131321","journal-title":"Br J Dermatol"},{"issue":"2","key":"4138_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/all.13309","volume":"73","author":"PP Vakharia","year":"2018","unstructured":"Vakharia PP, Chopra R, Sacotte R et al (2018) Validation of patient-reported global severity of atopic dermatitis in adults. Allergy 73(2):451\u2013458","journal-title":"Allergy"},{"issue":"4","key":"4138_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaad.2020.11.054","volume":"84","author":"JI Silverberg","year":"2021","unstructured":"Silverberg JI, Warshaw EM, Atwater AR et al (2021) Hand dermatitis in adults referred for patch testing: analysis of North American Contact Dermatitis Group Data, 2000 to 2016. J Am Acad Dermatol 84(4):989\u2013999","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4138_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40257-017-0340-7","volume":"19","author":"JL Owen","year":"2018","unstructured":"Owen JL, Vakharia PP, Silverberg JI (2018) The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol 19(3):293\u2013302","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"4138_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/DER.0000000000000208","volume":"27","author":"JK Chen","year":"2016","unstructured":"Chen JK, Jacob SE, Nedorost ST et al (2016) A pragmatic approach to patch testing atopic dermatitis patients: clinical recommendations based on expert consensus opinion. Dermatitis 27(4):186\u2013192","journal-title":"Dermatitis"},{"key":"4138_CR13","first-page":"20","volume":"20","author":"JI Silverberg","year":"2020","unstructured":"Silverberg JI, Lei D, Yousaf M et al (2020) What are the best endpoints for eczema area and severity index and scoring atopic dermatitis in clinical practice? A prospective observational study. Br J Dermatol 20:20","journal-title":"Br J Dermatol"},{"issue":"4","key":"4138_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/bjd.16078","volume":"178","author":"PP Vakharia","year":"2018","unstructured":"Vakharia PP, Chopra R, Sacotte R et al (2018) Severity strata for five patient-reported outcomes in adults with atopic dermatitis. Br J Dermatol 178(4):925\u2013930","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04138-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T23:26:39Z","timestamp":1743463599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04138-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JIS has received honoraria as a consultant and\/or advisory board member for Abbvie, Alamar, Aldena, Amgen, AObiome, Apollo, Arcutis, Arena, Asana, Aslan, Attovia, BioMX, Biosion, Bodewell, Boehringer-Ingelheim, Bristell-Meyers Squibb, Cara, Castle Biosciences, Celgene, Connect Biopharma, Corevitas, Dermavant, Eli Lilly, FIDE, Galderma, GlaxoSmithKline, Incyte, Inmagene, Invea, Kiniksa, Leo Pharma, Merck, My-Or Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, TARGET-RWE, Teva, Union, UpToDate JPT was previously an advisor for AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Pharmaceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, a speaker for AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, and received research grants from Pfizer, Regeneron, and Sanofi-Genzyme. He is currently an employee of LEO Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"652"}}